Our plenary speakers are:
Professor Michael Murphy of Cambridge University, UK. Mike’s interests are mitochondrial ROS production, and has pioneered methods to target mitochondrial ROS detection and scavenging. Mike has been a driving force behind triphenylphosphonium targeted small molecules, the most famous of which is Mito-Q.
Click Here – Professor Michael Murphy
Professor Clare Hawkins from University of Copenhagen. Clare’s research explores inflammation as a driving force in atherosclerosis, and how associated oxidants modify the structure and function of biological molecules and arterial wall cells. Clare’s group has a particular focus on hyperchlorous acid production from myeloperoxidase. Click Here – Professor Clare Hawkins
Professor Albert van der Vliet from Vermont University, USA. , Albert’s interests lie in understanding the molecular mechanisms by which biological and environmental oxidants mediate lung cell injury, inflammation, and remodelling, in chronic lung diseases such as asthma, COPD and lung cancer. Click Here – Professor Albert van der Vliet
Professor Roland Stocker
Head, Vascular Biology Division, Victor Chang Cardiac Research Institute
NHMRC Senior Principal Research Fellow, Conjoint Professor at UNSW
An international leader in redox biology. He has made seminal contributions and shifted paradigms in the field of oxidative processes and antioxidants in cardiovascular disease. His research discovered antioxidant activities of the bile pigment bilirubin and he identified the reduced form of coenzyme Q10 as an antioxidant in circulating lipoproteins. He also made key discoveries of the action of vitamin E during lipoprotein oxidation and delineated contributions of the latter to atherogenesis and pioneered work in heme oxygenase-1 and indoleamine 2,3-dioxygenase.